Stock Analysis
Amrize LtdAMRZ
P/E 17.01×· 1Y range 16.23–89.97×· bottom 4% of history
Sector: Basic Materials · Industry: Cement, Hydraulic
AnalystsBuy28 analystsP/E 17.0× sits at the 4th percentile of its 1.3141683778234086-year history.
Cash covers 10% of debt · Q2 2026.
PMP Verdict
Mixed fundamentals, cheap valuation
Strengths
- Quality80
Risks
- Growth36
- Financial Health37
Mixed business trading cheap — priced for skepticism.
Bull Case
- ✓P/E 17.0× at bottom 4% of 1-year history
What's happening with AMRZ
Profile
Strong valuation and earnings quality; growth, financial health and moat lag behind.
How is each axis scored?
- Valuation90/100 · Strong
- P/E vs own history (4th pct)25/25
- FCF yield (6.4%)20/25
- P/S (1.7x)25/25
- EV/EBIT (14.3x)20/25
- Growth36/100 · Weak
- Revenue CAGR (9.8%)12/25
- Net income CAGR (9.0%)12/25
- EPS CAGR 5Y (n/a)0/25
- Fwd implied growth (11.3%)12/25
- Profitability50/100 · Moderate
- ROIC (7.8%)5/25
- ROE (9.5%)12/25
- Net margin (10.0%)13/25
- Operating margin (15.5%)20/25
- Financial Health37/100 · Weak
- Altman Z (1.46)3/25
- Current ratio (1.10)12/25
- Interest coverage (4.6x)10/25
- Net cash / debt (D/A 26%)12/25
- Quality80/100 · Strong
- Piotroski F (6/9)15/25
- Beneish M (-2.26)20/25
- FCF conversion (109%)25/25
- Margin stability (σ 7.0%)20/25
- Moat49/100 · Weak
- ROIC >12% years (0/4 yrs)0/25
- Median gross margin (23.7%)6/25
- FCF-positive years (5/5 yrs)25/25
- Worst-year net margin (worst 8.2%)18/25
Risk Flags
- ⚠Altman Z 1.5 — distress-zone balance sheet
About Amrize Ltd
Amrize is a building solutions company focused exclusively on the North American market. Show more
Amrize earns revenue from the sale of cement, aggregates, ready-mix concrete, asphalt, roofing systems, and other building solutions. The company is organized into two reportable segments: building materials and building envelope. The building materials business consists of Amrize's cement, aggregates, ready-mix concrete, and asphalt operations. The building envelope segment offers advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings, along with adhesives, tapes, and sealants.
Headquarters: ZUG · Employees: 19,000 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
90A+P/E (TTM)17.0xB
Grade B: FairPrice / TTM EPS (own statements) — vs own 1Y history: 16.2x–90.0x · 4th pct
P/FCF—
Price / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield6.4%A
Grade A: ValueTTM (OCF − CapEx) / Market Cap — vs own 1Y history: -3.5%–6.7% · 95th pct
P/S (TTM)1.70xA
Grade A: CheapPrice / TTM Revenue (own statements) — vs own 1Y history: 1.6x–5.8x · 4th pct
EV/EBIT14.3xB
Grade B: FairEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 1Y history: 13.8x–55.7x · 5th pct
EV/Sales—
Enterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E15.3xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio1.61xA
Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio1.55B
Grade B: FairFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield—
TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio—
Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
50CROIC7.8%D
Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE9.5%D
Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks
ROA5.0%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin10.0%C
Grade C: AverageNet Income / Revenue
Operating Margin15.5%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin25.0%D
Grade D: LowGross Profit / Revenue
FCF Margin10.8%C
Grade C: AverageFCF / Revenue
True FCF Margin10.6%C
Grade C: AverageTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
36DRevenue CAGR9.8%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR9.0%C
Grade C: OkCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth11.3%B
Grade B: LowAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income2.5%A
Grade A: LowStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.3%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
37DAltman Z-Score1.46D
Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.10xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio0.69xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage4.6xC
Grade C: OkEBIT/Interest. >10 Strong
Debt Repayment4.8yC
Grade C: AverageYears to repay net debt via FCF
Net Debt/EBIT3.4xC
Grade C: MedLeverage. <2x Low, >4x High
Debt/Equity0.55xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.10xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Quality
80APiotroski F-Score6/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.26A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion108.6%A
Grade A: StrongFCF / Net Income
Margin Stability7.0%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue7.1%C
Grade C: AverageTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.50xC
Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Jenisch Jan Philipp Filed | Jenisch Jan Philipp | BuyOpen market buy | +2.0K | |
Jenisch Jan Philipp Filed | Jenisch Jan Philipp | BuyOpen market buy | +2.0K | |
Jenisch Jan Philipp Filed | Jenisch Jan Philipp | BuyOpen market buy | +1.0K | |
Jenisch Jan Philipp Filed | Jenisch Jan Philipp | BuyOpen market buy | +15.0K | |
Jenisch Jan Philipp Filed | Jenisch Jan Philipp | BuyOpen market buy | +10.0K |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Gibson Dwight Audley Konrad Filed | Gibson Dwight Audley Konrad | BuyOpen market buy | +5 | |
Sanche Jacques Wolf Filed | Sanche Jacques Wolf | BuyOpen market buy | +4.2K | |
Singleton Denise R Filed | Singleton Denise R | BuyOpen market buy | +3.5K |
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
49D+ROIC >12% Years0/4 yrsD
Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)23.7%D
Grade D: WeakMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years5/5 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor8.2%A
Grade A: DurableWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$2.22
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$1.33
Cash & short-term investments per share (Finnhub)
Book Value / Share$23.40
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$7.09B
Total debt obligations (short + long term)
Cash & Equiv.$729.00M
Cash and short-term investments
Net Debt$6.36B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$12.86B
Shareholders' equity (book value)
Asset / Liability2.09xA
Grade A: SolidTotal Assets / Total Liabilities
Market
Market Cap$20.68B
Current Market Capitalization
Beta0.91B
Grade B: MarketPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026
Key Insights: Amrize Ltd (AMRZ)
AMRZ is up 1.34% at the last close. Piotroski F-Score of 6/9 indicates mixed fundamentals for Amrize Ltd. Altman Z-Score of 1.46 is below the 1.81 distress threshold — an elevated financial-risk flag.
- Beneish M-Score of -2.26 suggests a low likelihood of earnings manipulation.
- Takes ~4.8 years to repay net debt from free cash flow.
- At a valuation score of 90/100, AMRZ trades near the cheapest end of its own historical range (P/E 17.0).
See how AMRZ ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all AMRZ moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Sep 22 | Pre-market | 39.77 | +3.06% | 2.16 |
Frequently Asked Questions about AMRZ
What is the current Amrize Ltd (AMRZ) stock price?
AMRZ is trading at $37.82 at the last market close, up 1.34% on the session. PreMarketPrice tracks AMRZ pre-market, intraday and after-hours prices.
Is AMRZ stock a buy right now?
PreMarketPrice's quantitative model rates Amrize Ltd's financial health at 37/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is AMRZ stock overvalued?
Amrize Ltd trades at a trailing P/E of 17.0 and our valuation score rates it 90/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Amrize Ltd report earnings?
No confirmed earnings date is currently scheduled for AMRZ. The Earnings section lists recent reports and updates as dates are announced.
What sector does Amrize Ltd operate in?
Amrize Ltd operates in the Basic Materials sector, within the Cement, Hydraulic industry. The Related Stocks section lists sector peers for comparison.
What does Amrize Ltd do?
Amrize is a building solutions company focused exclusively on the North American market.
About Amrize Ltd (AMRZ) Stock
Amrize Ltd (AMRZ) is a US-listed stock operating in the Basic Materials sector, specifically the Cement, Hydraulic industry. As of the latest update, Amrize Ltd is trading at $37.82, up 1.34% on the day with a market capitalization of $20.7 billion. The financial health score for AMRZ is 37/100, which indicates weak financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for AMRZ stock.
AMRZ Stock Analysis & Key Metrics
On PreMarketPrice, you can track Amrize Ltd (AMRZ) across multiple dimensions:
- Pre-market price & movement: Real-time AMRZ stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for AMRZ with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Amrize Ltd across multiple reporting periods.
- Financial health score: A composite score of 37/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for AMRZ.
- Sector peers: Compare AMRZ against 3 other basic materials stocks on key financial metrics.
Is AMRZ a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Amrize Ltd (AMRZ) as an investment. The financial health score of 37/100 suggests weak financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Amrize Ltd (AMRZ) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.